
Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.

α-Humulene Improves Cerebral Ischemia/Reperfusion Injury by Blocking KCNA3 to Inhibit Microglia Activation
Vol 38, Issue 4, 2024
Abstract
Background: α-Humulene (Hum) can alleviate cerebral ischemia/reperfusion (I/R) injury. However, the mechanism of Hum in microglial activation induced by cerebral I/R injury remains unclear. This study aims to investigate the role of Hum in microglial activation resulting from cerebral I/R injury. Methods: Several cerebral I/R injury models were established in adult Sprague-Dawley (SD) rats treated with 25 and 50 mg/kg Hum, and in primary microglia extracted from newborn SD rats treated with 0.25, 0.5, and 1.0 mM Hum. Neurological deficits were assessed using a modified neurological severity score. Cerebral infarction was assessed by triphenyltetrazolium chloride staining. Immunofluorescence assay was applied to measure the levels of potassium voltage-gated channel subfamily A member 3 (KCNA3) and ionized calcium-binding adapter molecule 1 (Iba-1). Gene expression levels of KCNA3, NOD-like receptor thermal protein domain-associated protein 3 (NLRP3), and brain-derived neurotrophic factor (BDNF) were measured by western blot and quantitative real-time polymerase chain reaction (qRT-PCR). The levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 were measured using enzyme-linked immune sorbent assay (ELISA). Additionally, a rescue assay was used to investigate whether the inhibitory effect of Hum on microglial activation was mediated through KCNA3 regulation. Results: Hum significantly reduced neurological deficits and cerebral infarction in rats with cerebral I/R injury (p < 0.001). Both in vivo and in vitro, Hum reduced the levels of Iba-1, KCNA3, and NLRP3, yet promoted the level of BDNF in cerebral I/R injury models (p < 0.01). Moreover, Hum suppressed the levels of TNF-α and IL-6 in oxygen-glucose deprivation/reperfusion (OGD/R)-exposed microglia (p < 0.001). Notably, KCNA3 overexpression reversed the effects of Hum on Iba-1, TNF-α, IL-6, NLRP3, and BDNF in OGD/R-exposed microglia (p < 0.001). Conclusion: Hum improves cerebral I/R injury by blocking KCNA3 to inhibit microglial activation.
Keywords
References
Supporting Agencies
Copyright (c) 2024 Yayun Sun, Quanbin Zha, Yongbin Ma, Dan Zhou, Junhua Zhang
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Medical Genetics, University of Torino Medical School, Italy

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy